Christopher C. Riedl

Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer

Christopher C. Riedl, Katja Pinker, Gary A. Ulaner et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 96 citations · Full text

Metastatic Breast Cancer, Engineering, Medical Imaging +13

Prospective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imaging for tumour location

Edwin C. Pratt, Magdalena Skubal, Benedict Mc Larney et al. · Nature Biomedical Engineering · 2022 · 55 citations · Full text

Positron Emission Tomography, Engineering, Clinical Cerenkov Luminescence +9

Imaging Phenotypes in Women at High Risk for Breast Cancer on Mammography, Ultrasound, and Magnetic Resonance Imaging Using the Fifth Edition of the Breast Imaging Reporting and Data System

Maria Adele Marino, Christopher C. Riedl, Maria Bernathova et al. · European Journal of Radiology · 2018 · 34 citations · Full text

Breast Oncology, Health Sciences, Medical Imaging +10

Association of PI3K Pathway Mutations with Early Positron-Emission Tomography/CT Imaging Response after Radioembolization for Breast Cancer Liver Metastases: Results of a Single-Center Retrospective Pilot Study

Amy R. Deipolyi, Christopher C. Riedl, Jacqueline Bromberg et al. · Journal of Vascular and Interventional Radiology · 2018 · 14 citations

Pi3k Pathway Mutations, Medicine, Pathology +7